glycochenodeoxycholic acid has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buist-Homan, M; Geng, Y; Moshage, H; Wu, Z | 1 |
| Ali, I; Beaudoin, JJ; Bezençon, J; Brouwer, KLR; Malinen, MM | 1 |
2 other study(ies) available for glycochenodeoxycholic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress.
Topics: Animals; Antioxidants; Apoptosis; Bile Acids and Salts; Cell Death; Cell Line, Tumor; Endoplasmic Reticulum Stress; Glycochenodeoxycholic Acid; Hep G2 Cells; Hepatocytes; Humans; Male; Necrosis; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitates; Rats; Rats, Wistar; Reactive Oxygen Species; Scopoletin; Signal Transduction; Umbelliferones | 2022 |
Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Topics: Bile Acids and Salts; Biological Transport; Biomarkers; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Glycochenodeoxycholic Acid; Hepatocytes; Humans; Liver; Liver Cirrhosis, Biliary; Male; Membrane Transport Proteins; Middle Aged; Non-alcoholic Fatty Liver Disease; Taurocholic Acid | 2018 |